DERM · Nasdaq
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
Journey Medical Corporation (the “ Company ”) is unable to file its Quarterly Report on Form 10-Q (the “ Form 10-Q ”) for the period ended March 31, 2023 within the prescribed time period without unreasonable effort and expense to the Company. On May 16, 2023, the Company and East West Bank (“ EWB ”) entered into an amendment (the “ Amendment ”) to the terms of the Company’s existing revolving line of credit and term loan with EWB (the “ EWB Facility ”). The Company needs additional time to assess the finalization impact of the Amendment on its financial statements to be issued with the Form 10-Q, including to prepare appropriate disclosures, and reach a conclusion with respect to whether, after giving effect to the Amendment, there are conditions or events, considered in the aggregate, that cause substantial doubt to exist about the Company’s ability to continue as a going concern as of the date of issuance of the Company’s financial statements to be included in the Form 10-Q. The Company continues to explore other financing arrangements that would provide additional liquidity to fund the Company’s operations for the next twelve months. The Company will file the Form 10-Q within the 5-day extension period provided by Rule 12b-25
NT 10-Q, filed 2023-05-16 · going concern
Journey Medical Corporation (the “ Company ”) is unable to file its Quarterly Report on Form 10-Q (the “ Form 10-Q ”) for the period ended March 31, 2023 within the prescribed time period without unreasonable effort and expense to the Company. On May 16, 2023, the Company and East West Bank (“ EWB ”) entered into an amendment (the “ Amendment ”) to the terms of the Company’s existing revolving line of credit and term loan with EWB (the “ EWB Facility ”). The Company needs additional time to assess the finalization impact of the Amendment on its financial statements to be issued with the Form 10-Q, including to prepare appropriate disclosures, and reach a conclusion with respect to whether, after giving effect to the Amendment, there are conditions or events, considered in the aggregate, that cause substantial doubt to exist about the Company’s ability to continue as a going concern as of the date of issuance of the Company’s financial statements to be included in the Form 10-Q. The Company continues to explore other financing arrangements that would provide additional liquidity to fund the Company’s operations for the next twelve months. The Company will file the Form 10-Q within the 5-day extension period provided by Rule 12b-25
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice